Navigation Links
Alacrita Launches 2012 Charity Auction of One-to-One Lunches with Senior Executives from the Pharmaceutical Industry
Date:12/4/2012

CAMBRIDGE, Massachusetts and LONDON, December 4, 2012 /PRNewswire/ --

Life Sciences Seasonal Appeal to Raise Funds for WaterAid

Alacrita, the transatlantic firm which is changing the face of life science consulting, is delighted to launch its 2012 Life Sciences Seasonal Appeal. Alacrita is offering the unique opportunity for individuals from the life sciences industry to bid for a two-hour, one-to-one lunch with senior executives from the pharmaceutical industry.

The Appeal aims to raise money for WaterAid (http://www.wateraid.org), an international non-profit organization that  transforms the lives of people in the world's poorest countries by improving access to safe water and sanitation. Bidding is open from Monday 3rd December and closes on Thursday 13th December and details are available on the Alacrita website.

Senior figures from the pharmaceutical industry who have kindly donated their time to the appeal include:

  • Heather Bell, Head of Corporate Strategy and Shaun Grady, Head of Business Development at AstraZeneca
  • Moncef Slaoui, Chairman, Research & Development at GlaxoSmithKline
  • Douglas Giordano, Senior Vice President, Worldwide Business Development at Pfizer
  • Susan Silbermann, President and General Manager, Vaccines, Specialty Care Business Unit and Polly Murphy Vice President, Specialty Care Business Unit Business Development at Pfizer
  • Graham Brazier, Vice President, Business Development, Strategic Transactions Group at Bristol-Myers Squibb
  • Pamela Demain, Executive Director, Corporate Licensing at Merck
  • Susan Jane Herbert, Executive Vice President and Head of Global Business Development and Strategy and Annalisa Jenkins, Executive Vice President and Head of Global Drug Development & Medical and Belen Garijo, Executive Vice President and Chief Operating Officer at Merck Serono

Bidding on the Alacrita auctions will be open until 13th December, 5pm EST/10pm GMT.

Rob Johnson, Partner at Alacrita, said: "We are thrilled to launch this year's seasonal appeal to raise funds for WaterAid. 783 million people, or one in ten of the world's population, live without access to safe water and last year WaterAid reached 1.6 million people with water and 1.9 million people with sanitation in 27 countries. This extremely worthwhile charity has made a significant positive impact on the lives of many people around the world and we are delighted to support its tremendous work. We are also hugely appreciative to the influential industry figures who are donating their time to the appeal. The auction provides the opportunity to spend a couple of hours over lunch building relationships with key pharma decision makers, gaining valuable insights into what science excites them."

David Winder, CEO of WaterAid, America, added: "We are delighted that Alacrita has chosen to  donate the proceeds of their charity auction to  WaterAid.  Every day, 2,000 children die from water-related diseases that could easily be prevented.  The funds raised will help us reach more of the world's poorest people with safe, clean water and sanitation.  These vital basic services are essential for saving  lives, improving health and reducing poverty in the world's poorest countries."

Notes to Editors

About Alacrita

Alacrita is a rapidly growing management consulting firm providing expertise-based services to the pharmaceutical, biotechnology and life science sectors. The firm has an unrivalled network of experts who operate across the spectrum of life sciences. They combine extensive international industry experience (strategic, technical and commercial), broad functional capabilities and a track record of success across the industry.

Since inception, Alacrita has completed successful consulting projects for big pharma, biotech companies, life science investors and government bodies.

http://www.alacritaconsulting.com

About WaterAid

WaterAid transforms lives by improving access to safe water, hygiene, and sanitation in the world's poorest communities. WaterAid works with partners and influences decision-makers to maximize its impact. Founded in 1981, WaterAid operates throughout Africa, Asia, the Pacific region and Central America and has helped 17.5 million people gain access to safe water through low-cost, sustainable projects that are locally managed and maintained.  WaterAid works with individuals and their families, paying special attention to the most vulnerable people, to help them set up, operate, manage and maintain their own projects.

http://www.wateraid.org.

For further information, please contact:
Rob Johnson or Anthony Walker at Alacrita
+1-781-249-3324 or +44-771-3402-771

Annie Bonner at WaterAid.
+1-212-683-0430


'/>"/>
SOURCE Alacrita
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. SurgLine International, Inc. Launches A Wholly Owned Operating Subsidiary To Pursue Cost Containment Strategies
3. Mylan Launches Generic Version of Zyprexa® Tablets
4. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
5. American Academy of Family Physicians Foundation Launches Cities for Life
6. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
7. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
8. Xtelligent Media Raises $800K in Funding and Launches EHRintelligence.com
9. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
10. Practice Fusion Launches API to Democratize Lab Integrations
11. Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Intarcia Therapeutics, Inc. today announced the appointment of ... created role of Vice President, Head of Global Medical ... of leadership experience at leading pharmaceutical, biotechnology, and health ... Most recently Dr. Yee served as VP, Head of ... Officer at AstraZeneca, where he led medical affairs across ...
(Date:2/8/2016)... BASEL , Switzerland and PALO ALTO, Calif. ... leader in biological and chemical manufacturing, and Kodiak Sciences ... for the treatment of retinal disease, announced today agreements ... the agreement, Lonza will manufacture material at multiple sites, ... --> --> Retinal ...
(Date:2/8/2016)... 2016 /PRNewswire/--  Cell Applications, Inc. and Cyfuse ... are now available in North America ... bioprinting approach called the "Kenzan Method." Utilizing Cyfuse ... state-of-the-art robotic system that fabricates 3D tissue from ... bio-printing model that makes scaffold-free tissue available immediately ...
Breaking Medicine Technology:
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... Discover the ... visit over 1,400 booths and 700 companies. Attendees also get to see the ... Colorado Garden & Home Show , at the Colorado Convention Center - 700 ...
(Date:2/8/2016)... ... 2016 , ... The Association of Home Care Coding & ... Health and Hospice ICD-10 Transition Workgroup are working closely with the American Hospital ... to address concerns over the use of 'A' as the seventh character indicating ...
(Date:2/8/2016)... Vegas, Nevada (PRWEB) , ... February 08, 2016 ... ... at RowdMap, Inc., will be speaking on how healthcare companies can use newly ... costs, manage the health of a population and intervene and capture the value ...
(Date:2/8/2016)... ... ... The schedule is now online for the largest and most ... being held May 25-29 at the Loews Chicago O’Hare Hotel, continues to give the ... chronic illness in children. , Very recent articles have cited 1 child in 20 ...
(Date:2/7/2016)... Michigan (PRWEB) , ... February 07, 2016 , ... ... organ prolapse with the latest techniques and the most minimally invasive approaches. , ... organ prolapse, particularly after menopause. Other risk factors include surgery to the pelvic ...
Breaking Medicine News(10 mins):